StockNews.AI
OSCR
StockNews.AI
28 days

Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance

1. Oscar Health reports a $230 million operational loss for Q2 2025. 2. The company's financial outlook for 2025 has been adversely updated.

Earnings
+9.73%Current Return
VS
+0.5%S&P 500
$13.6207/22 06:14 AM EDTEvent Start
$14.94507/23 01:00 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Very Bearish?

Oscar's projected operational losses signal significant financial distress akin to past performance dips seen in similar healthcare tech companies, which typically lead to stock price declines.

How important is it?

The announcement of substantial operational losses is a critical indicator of Oscar’s financial health affecting its stock.

Why Short Term?

Immediate investor reactions to poor Q2 results could lead to rapid stock price fluctuations based on sentiment.

Related Companies

UNHCVSANTM
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data (“2Q Risk Adjustm.

Related News